相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PD-L1 expression and survival in p16-negative and -positive squamous cell carcinomas of the vulva
Bastian Czogalla et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
CD274 (PD-L1), CDKN2A (p16), TP53, and EGFR immunohistochemical profile in primary, recurrent and metastatic vulvar cancer
Sofia Lerias et al.
MODERN PATHOLOGY (2020)
A pre-existing coordinated inflammatory microenvironment is associated with complete response of vulvar high-grade squamous intraepithelial lesions to different forms of immunotherapy
Ziena Abdulrahman et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
CD163+cytokine-producing cDC2 stimulate intratumoral type 1 T cell responses in HPV16-induced oropharyngeal cancer
Saskia J. Santegoets et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Blockade of immune checkpoints in lymph nodes through locoregional delivery augments cancer immunotherapy
David M. Francis et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
PD-L1 and IDO expression in cervical and vulvar invasive and intraepithelial squamous neoplasias: implications for combination immunotherapy
Zachary Chinn et al.
HISTOPATHOLOGY (2019)
Efficacy of PD-1 blockade in cervical cancer is related to a CD8+FoxP3+CD25+ T-cell subset with operational effector functions despite high immune checkpoint levels
A. M. Heeren et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Unlocking the therapeutic potential of primary tumor-draining lymph nodes
Jossie Rotman et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Clinical impact of PD-L1 and PD-1 expression in squamous cell cancer of the vulva
Fabinshy Thangarajah et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node
Kim M. van Pul et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial
R. Wendel Naumann et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status
Kim E. Kortekaas et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
The Immune System Computes the State of the Body: Crowd Wisdom, Machine Learning, and Immune Cell Reference Repertoires Help Manage Inflammation
Irun R. Cohen et al.
FRONTIERS IN IMMUNOLOGY (2019)
PD-L1 receptor expression in vulvar carcinomas is HPV-independent
M. Choschzick et al.
VIRCHOWS ARCHIV (2018)
Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapy
Marieke F. Fransen et al.
JCI INSIGHT (2018)
PD-L1 expression on immune cells is a favorable prognostic factor for vulvar squamous cell carcinoma patients
Jacek J. Sznurkowski et al.
ONCOTARGET (2017)
Tumoral PD-L1 expression defines a subgroup of poor-prognosis vulvar carcinomas with non-viral etiology
Thomas Hecking et al.
ONCOTARGET (2017)
Local immune response depends on p16INK4a status of primary tumor in vulvar squamous cell carcinoma
Jacek J. Sznurkowski et al.
ONCOTARGET (2017)
Melanoma Sequentially Suppresses Different DC Subsets in the Sentinel Lymph Node, Affecting Disease Spread and Recurrence
Mari F. C. M. van den Hout et al.
CANCER IMMUNOLOGY RESEARCH (2017)
The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer
Jacek J. Sznurkowski et al.
BMC CANCER (2016)
Squamous precursor lesions of the vulva: current classification and diagnostic challenges
Lien N. Hoang et al.
PATHOLOGY (2016)
Genetic Basis for PD-L1 Expression in Squamous Cell Carcinomas of the Cervix and Vulva
Brooke E. Howitt et al.
JAMA ONCOLOGY (2016)
Adjuvant Therapy in Lymph Node-Positive Vulvar Cancer: The AGO-CaRE-1 Study
Sven Mahner et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Adjuvant Therapy in Lymph Node-Positive Vulvar Cancer: The AGO-CaRE-1 Study
Sven Mahner et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
The clinical impact of using p16INK4a immunochemistry in cervical histopathology and cytology: An update of recent developments
Christine Bergeron et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Expression of coinhibitory receptors on T cells in the microenvironment of usual vulvar intraepithelial neoplasia is related to proinflammatory effector T cells and an increased recurrence-free survival
Edith M. G. van Esch et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Extensive Profiling of the Expression of the Indoleamine 2,3-Dioxygenase 1 Protein in Normal and Tumoral Human Tissues
Ivan Theate et al.
CANCER IMMUNOLOGY RESEARCH (2015)
High and Interrelated Rates of PD-L1(+)CD14(+) Antigen-Presenting Cells and Regulatory T Cells Mark the Microenvironment of Metastatic Lymph Nodes from Patients with Cervical Cancer
A. Marijne Heeren et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Subtypes of cytotoxic lymphocytes and natural killer cells infiltrating cancer nests correlate with prognosis in patients with vulvar squamous cell carcinoma
Jacek Jan Sznurkowski et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Suppression of Langerhans cell activation is conserved amongst human papillomavirus α and β genotypes, but not a μ genotype
Diane M. Da Silva et al.
VIROLOGY (2014)
Controlled Local Delivery of CTLA-4 Blocking Antibody Induces CD8+ T-Cell-Dependent Tumor Eradication and Decreases Risk of Toxic Side Effects
Marieke F. Fransen et al.
CLINICAL CANCER RESEARCH (2013)
IL-10 Conditioning of Human Skin Affects the Distribution of Migratory Dendritic Cell Subsets and Functional T Cell Differentiation
Jelle J. Lindenberg et al.
PLOS ONE (2013)
Expansion of a CD8+PD-1+ Replicative Senescence Phenotype in Early Stage CLL Patients Is Associated with Inverted CD4:CD8 Ratios and Disease Progression
Claudia Nunes et al.
CLINICAL CANCER RESEARCH (2012)
Status of cellular immunity lacks prognostic significance in vulvar squamous carcinoma
R. A. de Jong et al.
GYNECOLOGIC ONCOLOGY (2012)
Activation of the noncanonical NF-κB pathway by HIV controls a dendritic cell immunoregulatory phenotype
Olivier Manches et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Characterization of four conventional dendritic cell subsets in human skin-draining lymph nodes in relation to T-cell activation
Rieneke van de Ven et al.
BLOOD (2011)
The ICOS/ICOSL Pathway Is Required for Optimal Antitumor Responses Mediated by Anti-CTLA-4 Therapy
Tihui Fu et al.
CANCER RESEARCH (2011)
Expression of indoleamine 2,3-dioxygenase predicts shorter survival in patients with vulvar squamous cell carcinoma (vSCC) not influencing on the recruitment of FOXP3-expressing regulatory T cells in cancer nests
Jacek J. Sznurkowski et al.
GYNECOLOGIC ONCOLOGY (2011)
Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia
S. Daayana et al.
BRITISH JOURNAL OF CANCER (2010)
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia.
Gemma G. Kenter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
CTLA-4 blockade increases IFNγ-producing CD4+ICOShi cells to shift the ratio of effector to regulatory T cells in cancer patients
Chrysoula I. Liakou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The tumor-draining lymph node as an immune-privileged site
David H. Munn et al.
IMMUNOLOGICAL REVIEWS (2006)
A postmigrational switch among skin-derived dendritic cells to a macrophage-like phenotype is predetermined by the intracutaneous cytokine balance
TD de Gruijl et al.
JOURNAL OF IMMUNOLOGY (2006)
Tumour immunology - Tumour-induced immune modulation of sentinel lymph nodes
Alistair J. Cochran et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes
DH Munn et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Plasmacytoid dendritic cells (natural interferon-α/β-producing cells) accumulate in cutaneous lupus erythematosus lesions
L Farkas et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
分享论文
